Monodox

   
Google
 
Web NewDrugInformation.com

Monodox


Drug - Monodox
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Doxycycline
Multiple ingredients are in alphabetical order.

Strength - EQ 50MG BASE
The potency of the active ingredient(s), Doxycycline. May repeat for multiple part products.

Applicant - OCLASSEN
The firm name holding legal responsibility for Monodox. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 050641
The FDA assigned number to Monodox. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Monodox. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Feb 10, 1992
The date Monodox was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Monodox. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Monodox is in. Format is RX, OTC, DISCN.

Applicant Full Name - Oclassen Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Monodox.

Monodox